Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID06059586

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Led by Indiana University · Updated on 2026-02-27

20

Participants Needed

3

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to explore the feasibility of adding pelvic health physical therapy before radiation treatment for women diagnosed with cervical, vaginal, vulvar, uterine, or anal cancer who are candidates for curative pelvic external beam radiation. The study focuses on addressing side effects like pelvic pain and painful intercourse, which can affect quality of life after treatment. It seeks to understand challenges and benefits of coordinating pelvic health therapy with standard radiation care. Participants will receive education on using a vaginal dilator, a device designed to help maintain vaginal canal openness and stretch pelvic floor muscles, during their radiation treatment. The study combines pelvic health therapy involving assessments and vaginal dilator education with standard radiation therapy, delivered in collaboration between physical therapists and radiation oncology staff. Treatment includes physical therapy evaluations, questionnaires, and ongoing support throughout the radiation period. During the study, participants will complete questionnaires on pain and sexual function at various points including immediately after radiation and up to 16 weeks post-treatment. Researchers will monitor adherence to vaginal dilator use and assess pelvic pain using a pain rating scale. The main outcome is to evaluate the feasibility of this pre-rehabilitation approach alongside radiation therapy. The total participation duration covers baseline through several follow-up assessments over months after radiation.

CONDITIONS

Brief Title

Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female
  • 18 years old or older at the time of informed consent
  • Able to provide written informed consent and HIPAA authorization
  • Primary diagnosis of cervical, vaginal, vulvar, uterine, or anal cancer
  • Candidate for curative pelvic radiation with external beam, with or without brachytherapy
  • May have prior or current treatment including surgery and chemotherapy
  • Able to attend physical therapy visits at IUH North/Schwarz Cancer Center
Not Eligible

You will not qualify if you...

  • Major medical illnesses or psychiatric conditions that would prevent therapy or follow-up
  • Not a candidate for curative radiation therapy
  • Prior radiation therapy to the pelvis
  • Pregnant or nursing women

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Pre-Rehabilitation (Outpatient Treatment)

Duration - Up to radiotherapy start

Participants receive pelvic health therapy including physical therapy evaluation, pelvic floor muscle examination, and vaginal dilator education before starting pelvic radiotherapy.

Multiple outpatient visits before radiation therapy

Pelvic Radiotherapy Treatment

Duration - Varies according to radiation schedule

Participants undergo curative pelvic radiation therapy with external beam, with or without brachytherapy.

Radiotherapy visits as scheduled by oncology team

Post-Radiotherapy Follow-up

Duration - Up to 16 weeks post radiation

Participants are monitored for pelvic pain, sexual function, and adherence to vaginal dilator use after completing radiation therapy.

Follow-up visits at radiation completion and at 4, 6, 8, 12, and 16 weeks post radiation

Trial Site Locations

Total: 3 locations

1

IU Health West

Avon, Indiana, United States, 46123

Actively Recruiting

2

IU Health Schwarz Cancer Center

Carmel, Indiana, United States, 46032

Actively Recruiting

3

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

N

Namita Agrawal, MD

S

Sarah Dutkevich, RN

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Similar Trials

Multi-Site Randomized Controlled Trial of a Novel Digital Ap...

Sexual Dysfunction

Actively Recruiting

3 locations

A Novel Target Delineation Scheme Based on RTOG and EORTC Gu...

Radiation Toxicity

Actively Recruiting

1 location

A Phase I Study to Determine the Preferred Dose of Lisinopri...

Prostate Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here